Coramitug is well tolerated and leads to a statistically significant reduction in N-terminal pro-brain type natriuretic peptide (NT-proBNP)—a marker of disease progression in transthyretin-mediated ...

The mean cost savings associated with tafamidis treatment due to a reduction in hospitalization because of heart failure and shortening of length of stay in the hospital was $12,940 per patient.

The ratio of posterior wall thickness to the minimum voltage of QRS complexes in limb leads and several parameters derived from electrocardiography could independently predict ATTR-CM. The ratio of ...

Diagnosis of neurofibromatosis type 1 (NF1) requires a combination of clinical assessment, genetic testing, and imaging studies. 1 NF1 is a rare genetic disorder characterized by the development of ...

While there is currently no cure, pharmacological therapies for progressive pulmonary fibrosis (PPF) include immunomodulatory agents that aim to reduce inflammation and antifibrotics that delay ...

A single-cell RNA-sequential analysis of B cells in AAV has demonstrated significant alterations in B-cell populations and their functional features. Although ANCA-specific B cells are known to play a ...

NMOSD is a rare autoimmune disorder characterized by inflammation and demyelination of nerves in the central nervous system (CNS), particularly the optic nerves and spinal cord. It typically manifests ...